Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| GALECTIN (NASDAQ: GALT) | Delayed: 3.38 +0.19 (5.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.19 | 52 Week High | $3.05 | |||
| Open | $3.21 | 52 Week Low | $0.49 | |||
| Day High | $3.44 | P/E | N/A | |||
| Day Low | $3.13 | EPS | $-1.32 | |||
| Volume | 204,734 | |||||
